Fragment-Based Drug Discovery Based on Diversity-Oriented SynthesisWednesday, 18 February 2015 at 11:45 Add to Calendar ▼2015-02-18 11:45:002015-02-18 12:45:00Europe/LondonFragment-Based Drug Discovery Based on Diversity-Oriented SynthesisDiscovery Chemistry Congress in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com The application of diversity-oriented synthesis(DOS) to fragment-based drug discovery (FBDD) provides enhanced opportunities for both the discovery of novel ligands to disease targets and their optimization to therapeutic leads. |